Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?
The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.